Hey, big spender! Pfizer joins top 10 advertisers

Share this article:
Pfizer boosted ad spend 12% for the first nine months of 2009 over the same period in 2008, even as ad spend for the sector remained static and spending across all sectors plummeted 14.7%, according to TNS Media Intelligence.

Pfizer was the only pure-play pharmaceutical company among the top 10 advertisers, at No. 8 with $896.6 million in measured media spending for the January-to-September period. Johnson & Johnson, a perennial big spender with its strong consumer products business, was listed at No. 5 with $1 billion in ad spend – down 1.3% over the same period last year. Sprint Nextel was the only advertiser other than Pfizer to increase spending, having cut its marketing budget deeply in 2008.

TNS said some of Pfizer's increased spending could be attributed to its acquisition of Wyeth, but that the bump was “primarily attributable to its own portfolio of prescription drugs, particularly Lipitor and Caduet.”

Spending for the pharmaceutical sector was up 0.6% to $3.4 billion for the nine-month period.

Across all categories, spending was down 15.3% for the third quarter of 2009, making it the sixth consecutive quarter of year-over-year declines, and a whopping 25.1% for network TV. However, magazine, newspaper and radio losses for the quarter “were less severe compared to the first half of the year,” said TNS.

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.